Related Experiment Video
Updated: Jun 19, 2025
08:27
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.4K
Recent Advances in Biomaterials for mRNA Delivery to Immune Cells
Ivan Isaac1, Mayurakkhi Bhatia1, Chandrabali Bhattacharya1,2
1Department of Chemistry and Biochemistry, University of Nevada─Las Vegas 4505 S. Maryland Parkway, Las Vegas, Nevada 89154, United States.
ACS Applied Bio Materials
|July 26, 2024
Summary
Biomaterials are crucial for delivering messenger RNA (mRNA) to immune cells, enhancing immunotherapy for diseases like cancer. This review explores advanced biomaterials and delivery challenges for more effective immune cell targeting.
Area of Science:
- Immunology
- Biomaterials Science
- Nanotechnology
Background:
- Immune cell modulation is a cornerstone of immunotherapy for cancer, autoimmune diseases, and infections.
- Messenger RNA (mRNA) enables transient protein expression for genetic manipulation but requires effective delivery systems.
- Immune cells present significant barriers to transfection, including resistance mechanisms and complex signaling.
Purpose of the Study:
- To review recent advancements in biomaterials for mRNA delivery to immune cells.
- To discuss the challenges associated with targeting and delivering therapeutic payloads to immune cells.
- To provide an outlook on the design of next-generation biomaterials for immune cell mRNA delivery.
Main Methods:
- Review of current literature on biomaterial-based mRNA delivery systems.
- Analysis of lipid nanoparticles and polymeric carriers for immune cell transfection.
- Discussion of targeting strategies and challenges in immune cell delivery.
Main Results:
- Lipid nanoparticles and polymeric carriers are key biomaterials for mRNA delivery to immune cells.
- Overcoming immune cell resistance and achieving precise targeting remain significant challenges.
- Next-generation biomaterials require innovative designs for enhanced efficacy and safety.
Conclusions:
- Biomaterial-mediated mRNA delivery holds significant potential for advancing immunotherapy.
- Improved targeting and delivery strategies are essential for maximizing therapeutic benefits.
- This approach is poised to revolutionize treatments for immune-related conditions.
Related Concept Videos
02:31Nuclear Export of mRNA
7.6K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.6K
02:22Regulated mRNA Transport
6.3K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.3K